Research press release


Nature Medicine

Racial differences in platelet function


Paul Brayたちは、154人の健康な被験者(人種について、黒人か白人かを自己申告した)から得た血小板を比較し、黒人由来の血小板ではマイクロRNAの1つ、miR-376cのレベルが低下していることを発見した。miR-376cレベルが低いために、その標的タンパク質量も増加していた。この標的タンパク質は、血液凝固を促進する酵素トロンビンによる血小板の完全活性化に必要なタンパク質である。


Platelets in blood taken from black participants are more readily activated than those from white participants, reports a study published online this week in Nature Medicine. As activation of platelets can lead to excessive blood clotting, this work may help to explain why black individuals have lower survival rates from coronary heart disease compared to white individuals.

Paul Bray and his colleagues compared platelets from 154 healthy participants who self-identified their race as either black or white, and found that platelets from black individuals had decreased levels of the microRNA miR-376c. This decreased level in turn led to increased amounts of its target protein. This protein is needed for full platelet activation by thrombin, an enzyme that promotes blood clotting.

These findings highlight the concept that racial differences in clinical responses to anti-thrombotic drugs need to be taken into account, particularly in the case of drugs designed to inhibit thrombin activity.

doi: 10.1038/nm.3385


メールマガジンリストの「Nature 関連誌今週のハイライト」にチェックをいれていただきますと、毎週各ジャーナルからの最新の「注目のハイライト」をまとめて皆様にお届けいたします。